insights_auto
Why is UTH up 2.16%?
Dive Deeperchevron_right
UTH:FRA
United Therapeutics Corp
€481.50
arrow_upward
+2.16%(+10.20) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTH...
Open
€472.10
High
€481.50
Low
€472.10
Mkt. cap
23.55B
Avg. vol.
11.00
Volume
100.00
52-wk high
€522.80
52-wk low
€356.90
No. of employees
1K
Open
€472.10
High
€481.50
Low
€472.10
Mkt. cap
23.55B
Avg. vol.
11.00
Volume
100.00
52-wk high
€522.80
52-wk low
€356.90
No. of employees
1K
News stories
From web sources and news partners
Investing.com
·
3 hours ago
United Therapeutics CEO Martine Rothblatt sells $5.1m in shares
Investing.com Nigeria
·
3 hours ago
Form 4 United Therapeutics Corporation For: 10 October By Investing.com
www.marketscreener.com
·
1 day ago
United Therapeutics Insider Sold Shares Worth $5,075,919, According to a Recent SEC Filing
Traders Union
·
1 day ago
What's behind United Therapeutics's latest 3.6% stock surge?
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com